REUMATOLOGISK SPECIALLÆGEKLINIK ApS LONE SVENDSEN
CVR number: 32063128
Højdedraget 21 B, 8660 Skanderborg
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 124.66 | 2 157.98 | 2 500.01 | 3 788.61 | -74.64 |
| Employee benefit expenses | -1 339.85 | -1 075.84 | -1 284.06 | -1 119.03 | |
| Total depreciation | - 164.71 | - 105.80 | -40.03 | -16.99 | |
| EBIT | 620.10 | 976.34 | 1 175.92 | 2 652.59 | -74.64 |
| Other financial income | 71.67 | 58.56 | |||
| Other financial expenses | -0.26 | -1.20 | -5.53 | - 254.96 | -0.67 |
| Pre-tax profit | 619.84 | 975.15 | 1 170.39 | 2 469.29 | -16.75 |
| Income taxes | - 136.44 | - 214.78 | - 224.62 | - 586.70 | |
| Net earnings | 483.40 | 760.36 | 945.77 | 1 882.59 | -16.75 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 203.27 | 155.09 | 116.54 | ||
| Tangible assets total | 203.27 | 155.09 | 116.54 | ||
| Other receivables | 104.21 | 105.73 | 105.73 | ||
| Investments total | 104.21 | 105.73 | 105.73 | ||
| Non-current loans receivable | 2.00 | 2.00 | 2.00 | ||
| Long term receivables total | 2.00 | 2.00 | 2.00 | ||
| Inventories total | |||||
| Current trade debtors | 253.20 | 297.33 | 278.78 | ||
| Prepayments and accrued income | 3.92 | 3.65 | 3.83 | ||
| Current other receivables | 0.52 | 284.20 | |||
| Current deferred tax assets | 3.90 | 20.40 | 21.80 | ||
| Short term receivables total | 257.11 | 304.89 | 303.52 | 284.20 | 21.80 |
| Other current investments | 810.99 | 860.94 | |||
| Cash and bank deposits | 1 072.21 | 926.34 | 1 836.20 | 3 105.69 | 2 667.82 |
| Cash and cash equivalents | 1 072.21 | 926.34 | 1 836.20 | 3 916.68 | 3 528.76 |
| Balance sheet total (assets) | 1 638.80 | 1 494.06 | 2 364.00 | 4 200.87 | 3 550.56 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 108.00 | 113.00 | 114.40 | 117.80 | |
| Retained earnings | 565.69 | 49.09 | 696.46 | 1 527.82 | 3 292.62 |
| Profit of the financial year | 483.40 | 760.36 | 945.77 | 1 882.59 | -16.75 |
| Shareholders equity total | 1 282.09 | 934.46 | 1 880.22 | 3 649.81 | 3 518.67 |
| Provisions | 6.20 | ||||
| Non-current other liabilities | 5.09 | ||||
| Non-current liabilities total | 5.09 | ||||
| Current trade creditors | 38.76 | 47.03 | 30.35 | 30.00 | 20.00 |
| Short-term deferred tax liabilities | 115.74 | 176.88 | 192.12 | 506.20 | |
| Other non-interest bearing current liabilities | 190.92 | 335.69 | 261.31 | 14.86 | 11.89 |
| Current liabilities total | 345.42 | 559.60 | 483.78 | 551.06 | 31.89 |
| Balance sheet total (liabilities) | 1 638.80 | 1 494.06 | 2 364.00 | 4 200.87 | 3 550.56 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.